Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
- PMID: 36251175
- PMCID: PMC9828834
- DOI: 10.1007/s10067-022-06412-8
Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
Erratum for
-
Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients.Clin Rheumatol. 2022 Dec;41(12):3879-3885. doi: 10.1007/s10067-022-06348-z. Epub 2022 Sep 2. Clin Rheumatol. 2022. PMID: 36050514 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
